đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2009-04-01
Trial ID
NCT00871741
Treatments Being Tested
This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-08-13
Trial ID
NCT00970307
Treatments Being Tested
The purpose of this study is to evaluate immunogenicity and safety of menin...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-01
Trial ID
NCT01144663
Treatments Being Tested
This purpose of the study is to assess the safety and immunogenicity of a G...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-07
Trial ID
NCT01098474
Treatments Being Tested
The current trial will evaluate the safety and immunogenicity of GSK Biolog...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-08-18
Trial ID
NCT01171989
Treatments Being Tested
The purpose of the study is to investigate whether or not GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-05-09
Trial ID
NCT00674583
Treatments Being Tested
The purpose of this Phase II study is to evaluate the feasibility of GSK Bi...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-24
Trial ID
NCT00871338
Treatments Being Tested
This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05-17
Trial ID
NCT01090453
Treatments Being Tested